Beijing Tong Ren Tang Chinese Medicine Company Limited

Research Beijing Tong Ren Tang Chinese Medicine Company Limited (TQR) on Bullrun: market cap EUR 572.28M, P/E 13.5, dividend yield 6.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 572.28M; P/E is 13.5; dividend yield is 6.6%.

Peer valuation comparison

Latest P/E is 13.5x versus a Healthcare sector median of 24.46x (44.8% below).

Latest dividend yield is 6.55% versus a Healthcare sector median of 2.11% (210.4% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025HKD 1.51BHKD 397.22MHKD 788.34M61.2%0.47HKD 2.23BHKD 126.54MHKD 4.19B
FY2024HKD 1.61BHKD 500.28M-HKD 260.42M66.1%0.6HKD 1.77BHKD 123.42MHKD 4.08B
FY2023HKD 1.52BHKD 540.39MHKD 438.97M68.7%0.65HKD 999.81MHKD 131.81MHKD 3.87B
FY2022HKD 1.73BHKD 645.88MHKD 508.94M66.4%0.77HKD 1.99BHKD 103.08MHKD 3.60B
FY2021HKD 1.56BHKD 607.84MHKD 753.74M71.9%0.73HKD 1.66BHKD 128.48MHKD 3.42B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25EUR 572.28M13.56.3%0.04

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.04 EUR, yield 6.6%.

YearDividends/share
FY20250.04 HKD
FY20240.04 HKD
FY20230.04 HKD
FY20220.06 HKD
FY20210.03 HKD

About Beijing Tong Ren Tang Chinese Medicine Company Limited

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments. The company also offers Chinese medical consultation and treatment services. It markets its products under the Tong Ren Tang brand name.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Beijing Tong Ren Tang Chinese Medicine Company Limited's market cap?

Beijing Tong Ren Tang Chinese Medicine Company Limited's market capitalization is EUR 572.28M.

What is Beijing Tong Ren Tang Chinese Medicine Company Limited's P/E ratio?

Beijing Tong Ren Tang Chinese Medicine Company Limited's price-to-earnings (P/E) ratio is 13.5.

Does Beijing Tong Ren Tang Chinese Medicine Company Limited pay a dividend?

Beijing Tong Ren Tang Chinese Medicine Company Limited has a dividend yield of 6.6%.

What does Beijing Tong Ren Tang Chinese Medicine Company Limited do?

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments. The company also offers Chinese medical consultation and treatment services. It markets its products under the Tong Ren Tang brand name. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, the Oceania, North America, and Europe.